Literature DB >> 9675452

Surveillance of human Yersinia enterocolitica infections in Belgium: 1967-1996.

J Verhaegen1, J Charlier, P Lemmens, M Delmée, R Van Noyen, L Verbist, G Wauters.   

Abstract

Between 1967 and 1996, > 18,700 strains of Yersinia species, excluding Yersinia pestis, were recovered in Belgium from a variety of gastrointestinal and extraintestinal sites in patients. Full identification and serotyping were performed by the two Belgian reference laboratories. Yersinia enterocolitica serogroup O:3 predominated (79.4% of strains), followed by serogroup O:9 (11.1%). The remaining 9.5% of isolates belonged to serogroups and related species generally considered nonpathogenic. Acute enterocolitis was the most common clinical form of Y. enterocolitica infection, affecting primarily children younger than 5 years of age. Since 1967, there was a steady increase in isolations every year, with 305 cases in 1975 and up to 1,469 in 1986. From 1987 on, there was a clear decrease in the number of reported cases, although the number of participating laboratories and culture techniques remained constant. This significant decrease in the occurrence of Y. enterocolitica infections may be explained by changes in the slaughtering procedures and eating habits of the population.

Entities:  

Mesh:

Year:  1998        PMID: 9675452     DOI: 10.1086/514636

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Current evidence for human yersiniosis in Ireland.

Authors:  T Ringwood; B P Murphy; N Drummond; J F Buckley; A P Coveney; H P Redmond; J P Power; S Fanning; M B Prentice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

2.  Seroprevalence of anti-Yersinia antibodies in healthy Austrians.

Authors:  H Tomaso; G Mooseder; S Al Dahouk; C Bartling; H C Scholz; R Strauss; T M Treu; H Neubauer
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Epidemiology of reported Yersinia enterocolitica infections in Germany, 2001-2008.

Authors:  Bettina M Rosner; Klaus Stark; Dirk Werber
Journal:  BMC Public Health       Date:  2010-06-14       Impact factor: 3.295

4.  Yersinia enterocolitica-Specific Infection by Bacteriophages TG1 and ϕR1-RT Is Dependent on Temperature-Regulated Expression of the Phage Host Receptor OmpF.

Authors:  Carlos G Leon-Velarde; Lotta Happonen; Maria Pajunen; Katarzyna Leskinen; Andrew M Kropinski; Laura Mattinen; Monika Rajtor; Joanna Zur; Darren Smith; Shu Chen; Ayesha Nawaz; Roger P Johnson; Joseph A Odumeru; Mansel W Griffiths; Mikael Skurnik
Journal:  Appl Environ Microbiol       Date:  2016-08-15       Impact factor: 4.792

Review 5.  Low occurrence of pathogenic Yersinia enterocolitica in clinical, food, and environmental samples: a methodological problem.

Authors:  Maria Fredriksson-Ahomaa; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  Behavior of Yersinia enterocolitica in the presence of the bacterivorous Acanthamoeba castellanii.

Authors:  E Lambrecht; J Baré; I Van Damme; W Bert; K Sabbe; K Houf
Journal:  Appl Environ Microbiol       Date:  2013-08-09       Impact factor: 4.792

7.  Changing epidemiology of Yersinia enterocolitica infections: markedly decreased rates in young black children, Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2009.

Authors:  Kanyin L Ong; L Hannah Gould; Daniel L Chen; Timothy F Jones; Joni Scheftel; Tameka Hayes Webb; Rajal K Mody; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

8.  Thirty years of human infections caused by Yersinia enterocolitica in northern Spain: 1985-2014.

Authors:  J M Marimon; R Figueroa; P Idigoras; M Gomariz; M Alkorta; G Cilla; E Pérez-Trallero
Journal:  Epidemiol Infect       Date:  2017-06-05       Impact factor: 4.434

9.  Human and animal epidemic of Yersinia enterocolitica O:9, 1989-1997, Auvergne, France.

Authors:  F Gourdon; J Beytout; A Reynaud; J P Romaszko; D Perre; P Theodore; H Soubelet; J Sirot
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.